Nov
2026
IICC, Yashobhoomi, Dwarka, Delhi
Visit us
stand 2D29
Zone

K A Malle Pharmaceuticals Ltd.

Exhibitor at CPHI India 2026
About Us

K A Malle Pharmaceuticals Ltd is an Export House and a leading manufacturer of API's, Drug Intermediates, Specialty Chemicals and Hydrogenation.

We are the largest manufacturers of Mebendazole (all grades) globally and one of the largest manufacturers of Albendazole in India. We are the pioneers of hydrogenation. We undertake contract manufacturing of almost all MNC`s and reputed pharmaceuticals companies of India.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI India 2026
  • 23 Nov 2026 - 25 Nov 2026
  • IICC, Yashobhoomi, Dwarka, Delhi
  • Visit us at stand 2D29

Products Featured at CPHI India 2026

  • Albendazole

    Product Albendazole

    Ka Malle Pharmaceuticals Ltd offers a wide range of active pharmaceutical ingredient and intermediates which includes Albendazole. Capacity: 10 MT / month.
  • Hydrogenation

    Product Hydrogenation

    Ka Malle Pharmaceuticals Ltd offers a wide range of services hydrogenation contract manufacturing. It provides hydrogenation contract manufacturing for products like Aroma & Perfumery, Pharmaceutical Industries, Agro Products, Fine Chemicals, etc
  • Mebendazole

    Product Mebendazole

    Ka Malle Pharmaceuticals Ltd offers a wide range of active pharmaceutical ingredient and intermediates which includes Mebendazole. Capacity: 25 MT / month.
  • Meta Bromo Anisole (MBA)

    Product Meta Bromo Anisole (MBA)

    Ka Malle Pharmaceuticals Ltd offers a wide range of active pharmaceutical ingredient and intermediates which includes Meta Bromo Anisole (MBA). Capacity: 15 MT / month.
  • Meta Phenoxy Benzal Alcohol (MPBA)

    Product Meta Phenoxy Benzal Alcohol (MPBA)

    Ka Malle Pharmaceuticals Ltd offers a wide range of active pharmaceutical ingredient and intermediates which includes Meta Phenoxy Benzal Alcohol (MPBA). Capacity: 200 MT / month.